MBMA data curation: How AI and expert meta-analysts get it right, fast
In MBMA, the data layer is the real bottleneck. See how AI and expert meta-analysts…
Matt Zierhut, PhD MBA2026 年 8 月 14 日
A model-informed approach to radioligand therapy dosing under Project Optimus
Explore how targeted radionuclide therapy dosing uses QSP, biologically effective dose (BED), and exposure-response modeling…
Hunter Stephens, PhD2026 年 8 月 13 日
Managing drug-drug interaction (DDI) risk for patients in clinical trials
Discover how DIDB® helps clinical teams assess drug-drug interaction risk, develop prohibited medication lists, &…
Katie Owens, PhD2026 年 8 月 12 日
Advances and Challenges in Model-Informed Precision Dosing of Antimicrobials for Pediatric Patients
Explore advances in model-informed precision dosing (MIPD) for pediatric antimicrobial therapy, including population PK modeling,…
Certara2026 年 7 月 29 日
A novel mathematical framework to predict in vivo bispecific GTX-B001 binding in skin, and translation to humans
See how quantitative pharmacology and PBPK modeling supported first in human dose selection for a…
Certara2026 年 7 月 20 日
Current State-of-the-Art and Future Advancements of Model-Based Meta-Analysis
Explore how model-based meta-analysis supports dose optimization, trial design, and regulatory decisions, plus emerging roles…
Certara2026 年 7 月 16 日
